Hims & Hers Launches Weight-Loss Drugs in Australia

Telehealth company Hims & Hers has initiated the offering of branded GLP-1 weight-loss drugs and various treatments to men in Australia, marking a significant step in its international business growth. This expansion was facilitated by the company's acquisition of the Australian digital health platform Eucalyptus earlier this year, which includes its men's telehealth brand, Pilot.

Through Pilot, Hims & Hers will provide a range of products, from sexual health medications to cholesterol treatments, with a particular focus on weight-loss care. The company also intends to launch its women's health segment in Australia later this year, utilizing Eucalyptus's women's brand, Juniper. These expansions aim to enhance access to preventative healthcare and reduce travel and wait times for Australian consumers, addressing challenges like rural access.

Hims & Hers's strategic international expansion is crucial to its long-term revenue goals and has already contributed to increased subscriptions and monthly revenue per subscriber. The company previously acquired Zava, a UK-based firm, and continues to invest in diagnostic testing, manufacturing, and hormonal treatments to support its global ambitions.